Cite

HARVARD Citation

    Pompe, R. et al. (2018). Survival benefit of local versus no local treatment for metastatic prostate cancer—Impact of baseline PSA and metastatic substages. Prostate. 78 (10), pp. 753-757. [Online]. 
  
Back to record